{"DataElement":{"publicId":"6056548","version":"1","preferredName":"Target Lesion Response iRECIST Type","preferredDefinition":"Text term to represent disease response in a target lesion using the iRECIST criteria.","longName":"TGT_LES_RESP_IR_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188858","version":"1","preferredName":"Target Lesion Response","preferredDefinition":"Information relating to target lesion response.","longName":"TARGET_LES_RESP","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206598","version":"1","preferredName":"Target Lesion","preferredDefinition":"The goal intended to be attained.:(LEE-zhun) An area of abnormal tissue change.","longName":"C25702:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FBAD-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C180D-8CF4-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SOKKERL","dateModified":"2017-10-19","changeDescription":"8/31/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6056537","version":"1","preferredName":"iRECIST Target Type","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used._An object fixed as a goal or point of examination; something to point at; a destination._Something distinguishable as an identifiable class based on common qualities.","longName":"6056537v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"iSD","valueDescription":"iRECIST Stable Disease","ValueMeaning":{"publicId":"6056539","version":"1","preferredName":"iRECIST Stable Disease","longName":"6056539","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Stable Disease","conceptCode":"C142359","definition":"Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5A80-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"639DB17C-5A99-166C-E053-F662850A2137","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","deletedIndicator":"No"},{"value":"iPR","valueDescription":"iRECIST Partial Response","ValueMeaning":{"publicId":"6056541","version":"1","preferredName":"iRECIST Partial Response","longName":"6056541","preferredDefinition":"A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Partial Response","conceptCode":"C142358","definition":"A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5AA6-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"639DB17C-5ABF-166C-E053-F662850A2137","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","deletedIndicator":"No"},{"value":"iUPD","valueDescription":"iRECIST Unconfirmed Progressive Disease","ValueMeaning":{"publicId":"6056543","version":"1","preferredName":"iRECIST Unconfirmed Progressive Disease","longName":"6056543","preferredDefinition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Unconfirmed Progressive Disease","conceptCode":"C142360","definition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5ACC-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"639DB17C-5AE5-166C-E053-F662850A2137","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","deletedIndicator":"No"},{"value":"iCPD","valueDescription":"iRECIST Confirmed Progressive Disease","ValueMeaning":{"publicId":"6056545","version":"1","preferredName":"iRECIST Confirmed Progressive Disease","longName":"6056545","preferredDefinition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Confirmed Progressive Disease","conceptCode":"C142356","definition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5AF2-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"639DB17C-5B0B-166C-E053-F662850A2137","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","deletedIndicator":"No"},{"value":"iCR","valueDescription":"iRECIST Complete Response","ValueMeaning":{"publicId":"6056547","version":"1","preferredName":"iRECIST Complete Response","longName":"6056547","preferredDefinition":"The disappearance of all signs of cancer following an initial apparent radiographic progression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Complete Response","conceptCode":"C142357","definition":"The disappearance of all signs of cancer following an initial apparent radiographic progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5B18-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"639DB17C-5B31-166C-E053-F662850A2137","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","deletedIndicator":"No"},{"value":"NE","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3855538","version":"1","preferredName":"Unevaluable","longName":"3855538","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3FD8B-328D-C859-E040-BB89AD43580F","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E0ABFA4-48EF-2FC4-E053-F662850AB965","beginDate":"2019-07-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-19","modifiedBy":"ONEDATA","dateModified":"2019-07-19","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"4163021","version":"1","preferredName":"Not Done","longName":"4163021","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2B5E544-9A39-F7D4-E040-BB89AD4312F7","latestVersionIndicator":"Yes","beginDate":"2014-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-18","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E0990B8-968E-1DDB-E053-F662850A18B2","beginDate":"2019-07-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-19","modifiedBy":"ONEDATA","dateModified":"2019-07-19","deletedIndicator":"No"},{"value":"Not all evaluated","valueDescription":"Not All Lesions Evaluated","ValueMeaning":{"publicId":"4273169","version":"1","preferredName":"Not All Lesions Evaluated","longName":"4273169","preferredDefinition":"Not all target lesions were assessed. Or not all non-target lesions were assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not All Lesions Evaluated","conceptCode":"C103424","definition":"Not all target lesions were assessed. Or not all non-target lesions were assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72DFE87-DE58-5FDE-E040-BB89AD433D0A","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"COOPERM","dateModified":"2020-04-27","changeDescription":"Updated Long Name and Definition to match current NCIt. mc 4/27/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E0990B8-96A8-1DDB-E053-F662850A18B2","beginDate":"2019-07-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-19","modifiedBy":"ONEDATA","dateModified":"2019-07-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6056536","version":"1","preferredName":"Immune-Modified Response Evaluation Criteria in Solid Tumors Target Type","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.:An object fixed as a goal or point of examination; something to point at; a destination.:Something distinguishable as an identifiable class based on common qualities.","longName":"C136711:C25702:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","conceptCode":"C136711","definition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"639DB17C-5A54-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"ONEDATA","dateModified":"2018-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"639DB17C-5A65-166C-E053-F662850A2137","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"COOPERM","dateModified":"2020-04-27","changeDescription":"7/19/19 jk added PVs (NE, Not Done, Not all evaluated) for DCI MEL_PPD1_101803 study.  10/7/18 jk Released per Fall 2018 Content Team review.  1/25/18 jk created for EORTC iRECIST follow up measurement form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006601","version":"1","longName":"iRECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Target lesion response","type":"Preferred Question Text","description":"Target lesion response","url":null,"context":"NCI Standards"},{"name":"iRECIST","type":"Alternate Question Text","description":"Target lesion","url":null,"context":"NCI Standards"}],"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"63A0BC08-61D2-6CE9-E053-F662850AECD8","latestVersionIndicator":"Yes","beginDate":"2018-01-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-01-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"10/7/18 jk Released per Fall 2018 Content Team review.  1/25/18 jk created for EORTC iRECIST follow up measurement form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}